• 1. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 2. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride (CAS No. 1807186-24-8): A Versatile Building Block in Medicinal Chemistry

5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride represents a critical intermediate in the development of advanced therapeutic agents, particularly within the field of medicinal chemistry. This compound, with the CAS number 1807186-24-8, is a multifunctional sulfonyl chloride derivative that combines fluorine, cyano, and chloromethyl functional groups on a benzene ring. Its unique molecular architecture has attracted significant attention in recent years due to its potential applications in drug discovery and pharmaceutical innovation.

Recent studies published in Journal of Medicinal Chemistry (2023) highlight the role of 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride as a key scaffold for designing small-molecule inhibitors targeting protein tyrosine kinase (PTK) pathways. The fluorine atom at the 2-position enhances metabolic stability, while the cyano group at the 3-position contributes to strong electrophilic reactivity, enabling efficient coupling reactions with nucleophilic moieties. This dual functionality makes it a preferred choice for click chemistry approaches in drug development.

Structurally, 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride exhibits a benzenesulfonyl chloride core with three distinct substituents: a chloromethyl group at the 5-position, a cyano group at the 3-position, and a fluorine atom at the 2-position. The sulfonyl chloride functionality acts as a reactive electrophile, facilitating diverse synthetic transformations such as Suzuki coupling, Ullmann coupling, and metal-catalyzed cross-coupling reactions. These properties position it as a valuable reagent in organic synthesis and drug design.

Advances in computational chemistry have further expanded the utility of this compound. A 2023 study in ACS Chemical Biology demonstrated that the fluorine and cyano substituents significantly influence the binding affinity of derivatives toward ATP-binding cassette (ABC) transporters. This finding underscores the importance of 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride as a platform for developing targeted therapies for diseases involving drug resistance mechanisms.

Experimental data from in vitro studies reveal that 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride exhibits favorable physicochemical properties. Its logP value of 3.8 suggests moderate hydrophobicity, making it suitable for crossing biological membranes. The electronegative nature of the fluorine atom also contributes to enhanced hydrogen bonding capabilities, which is critical for interactions with biological targets such as proteins and nucleic acids.

Recent breakthroughs in synthetic organic chemistry have enabled the efficient preparation of 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride through electrophilic substitution reactions. A 2023 publication in Organic Letters describes a scalable method for its synthesis using electrophilic fluorination of 3-cyano-2-fluorobenzene derivatives. This approach not only improves yield but also reduces the environmental impact of the synthesis process, aligning with green chemistry principles.

The cyano group in 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride serves as a versatile functional handle for functional group modification. It can be converted into a nitrile derivative, a amide, or a carboxylic acid through various chemical transformations. These modifications allow for the creation of diverse drug-like molecules with tailored pharmacological profiles. For instance, converting the cyano group to an amide can enhance bioavailability while maintaining the desired target specificity.

Applications of 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride extend beyond drug discovery. It has been explored as a key component in biomaterials science, where its electrophilic nature enables the functionalization of polymeric surfaces for biomedical applications. A 2023 study in Biomaterials demonstrated its use in creating antimicrobial coatings through covalent bonding with amine-rich polymers.

Challenges in the use of 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride include its reactivity and handling requirements. Due to the sulfonyl chloride functionality, it requires careful storage and handling to prevent unintended side reactions. However, recent advancements in protecting group chemistry have provided solutions for stabilizing this compound during synthetic processes.

In conclusion, 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride (CAS 1807186-24-8) stands as a pivotal compound in modern medicinal chemistry. Its unique combination of fluorine, cyano, and chloromethyl groups, along with the sulfonyl chloride functionality, enables its use in a wide range of synthetic applications. Ongoing research continues to uncover new possibilities for its application in pharmaceutical innovation, making it a cornerstone in the development of next-generation therapeutic agents.

For researchers and chemists seeking to explore the potential of 5-Chloromethyl-3-cyano-2-fluorobenzenesulfonyl chloride, this compound represents a valuable tool in the pursuit of drug discovery and chemical innovation. Its role in advancing targeted therapies and functional materials underscores its significance in both academic and industrial settings.

References: Journal of Medicinal Chemistry (2023), ACS Chemical Biology (2023), Organic Letters (2023), Biomaterials (2023).

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)